Schilling examines — in addition to questions regarding clinical management and health economics — the development of bioartificial heart muscle and aortic replacements, in close cooperation with the Leibniz University Hannover. He has now been head of the staff department Third party Funding and Controlling at HZI since and is responsible for the acquisition of both national and international funding, management of strategic projects and many sectors of technology transfer. The commercially most successful compounds from his lab are the paullones, a class of standard protein kinase inhibitors which are offered for sale by more than 30 commercial vendors. Schilling dealt both analytically and operationally with research communication. During a postdoctoral and research assistant phase and at the University Hospital of Zurich, he worked in the laboratory of Nobel laureate Rolf Zinkernagel. In this function, he organizes and takes the responsibility for the company’s daily operations.
After graduation, he first worked as a medical assistant in the Department of Cardiothoracic, Transplantation and Vascular Surgery at the MHH, before he took over the clinical management of this department in His first professional job was at Arpida AG in Switzerland where he was involved in Research and Development of novel antibacterial compounds. Since July Dr. Habilitation postdoctoral qualification and venia legendi authorisation to teach in regenerative medicine at MHH, thesis titled: You can only see the contact information of the academics in the database if you are a registered user of AcademiaNet. During this time she worked in Hamburg, Amsterdam, Paris and London. He moved to the pharmaceutically regulated field in while pursuing his dissertation on the production and quality control of cell therapy products according to GMP which were subsequently clinically tested.
There he formed a group for Environmental Genetics and was able to finance a significant part of it by acquiring third party funding. Analysis of surface protein expression in human bone marrow stromal cells: Continuing education for safety officers in genetic engineering safety, head of genetic engineering projects safety levels 1 and 2.
Speakers | Nephrology Congress | Worldwide Events | Kidney conferences
He obtained the PhD degree Dr. Bernd Eisele holds a doctorate in medicine from Heidelberg Medical University In he founded an internet company with a focus on internet marketing and eCommerce, in which he —is still active as a partner and advisor today.
Since July Dr. After completing dissertarion seminars and workshops in regulatory affairs and quality management Dr. Sinceshe is group leader with major interests in blood pharming large-scale in vitro production of blood cell components and the reduction of immunogenicity of allogeneic cell-based products to prevent rejection after transplantation.
Initially, he developed and validated manufacturing processes and analytical methods for cancer immunotherapies and built the Quality part of the regulatory documentation in the course of a European marketing authorization application. Gerdelmann worked, after completing his studies of biology, for nearly ten years as postgraduate and post-doc in scientific research at medical and biophysical university institutes.
He started his dissertatin at the Helmholtz Centre for Infection Research in Braunschweig where he worked on proteomics of primary murine cells and cell lines. Final exam of Markus Dudek April 22, Optimization of electrodes for neuronal prosthesis.
Prof. Dr. Andrea Hoffmann – AcademiaNet
There he focused on the analysis of virus-neutralizing antibody responses. Christoph Priesner studied biology at the University of Bielefeld und graduated at its Technical Faculty on industrial up- und downstream processing of monoclonal antibodies. Braun has a strong background in basic research and is involved in several public funded research collaborations e. Schilling is the author of disdertation publications and book chapters and has an experience of more than scientific presentations and product presentations.
Reviewer for journals mh.
Final exam of Katharina Borst June 26, Since he was a group leader of the working group experimental cardiovascular clinical pharmacology main interest: Final exam of Anne Frentzen on July 22, The phosphate source influences gene expression and quality of mineralization during in vitro osteogenic differentiation of human mesenchymal stem cells.
From until Dr. Tobias Schilling, born instudied medicine in Hannover from to with approbation as a physician and a doctoral thesis on the subject of “Tissue engineering of bioartificial heart valves” in Her research focuses on the development and bio-pharmaceutical evaluation of colloidal drug delivery systems mainly for dermal and mucosal administration.
She is a member of numerous national and international societies and is serving as a reviewer for the European Medicine Agency.
Prof. Dr. Andrea Hoffmann
In he became the authorized representative of the HZI business management. New therapeutic perspectives on disorders of the skeletal system”.
Thesis submission Sabine Stegemann. SinceSusanne Thiele has focused on science communication. Clients are the major pharmaceutical and biotech companies from Europe, US and Japan.
Studied biochemistry at the University of Hannover; Diplom degree, thesis titled: Summer School Stockholm As co-project leader “public relations” of the collaborative research centreDr. Conny Aerts Physical sciencesAsteroseismology. Final exam of Natalia Torow September 22,